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ABSTRACT 
 
Objective  
To compare the peak expiratory flow rate of diabetic patients with normal 
populations and to study the association of duration of diabetes mellitus, fasting blood 
sugar value in relation to Peak Expiratory Flow Rate.  
 
Study Design  
Descriptive study, prospective randomized design 
Setting 
Priya clinic and diabetic center, combatore. 
Participants  
50 diabetic females and 50 normal populations.  
Methods  
50 Type 2 diabetic and 50 normal populations were selected. Their fasting blood 
sugar values, PEFR, duration of diabetes, anthropometric details were collected & 
documented. PEFR values between diabetic & controls were compared.  
 
 
 
 
 
 
Results 
Peak expiratory flow rate is significantly higher for diabetics compared to controls 
(‘t’ test value 26.810 significant at 0.01 level). There is significant association, significant 
at .01 level) ie PEFR is less as duration of diabetes is more. But there is no association 
between the value of FBS and PEFR (‘r’ value is -.176).  
 
Conclusion  
Peak expiratory flow rate is significantly reduced in diabetics when compared to 
controls (P<0.01) group participants. There is a significant associated between the 
duration of diabetes and PEFR (P<0.01), An inverse relationship was found between the 
PEFR and the duration of diabetes, PEFR was found to be low in the participants with 
longer duration of diabetes and vice versa. There was no association between the fasting 
blood sugar and PERF in diabetic patients 
 
Key words  
Peak expiratory flow meter, Type II diabetes mellitus, fasting blood sugar, body 
mass index. 
 
 
 
 
EXPLANATION FOR ABBREVIATION 
 
DM   : Diabetes mellitus 
PEFR   : Peak expiratory flow rate 
BL   : Basal lamina 
FVC   : Forced vital capacity 
FEV1   : Forced expiratory volume in one second 
DLCo   : Diffusion capacity for carbon monoxide 
FBS   : Fasting blood sugar  
TLC   : Total lung capacity 
NIDDM  : Non insulin dependent diabetes mellitus 
PFT   : Pulmonary function test 
PaO2   : Partial pressure of oxygen 
PaCO2  : Partial pressure of carbon dioxide 
BMI   : Body mass index 
 
ABSTRACT 
Objective 
 
To compare the peak expiratory flow rate of diabetic patients with normal 
populations and to study the association of duration of diabetes Fasting blood 
sugar value in relation to Peak Expiratory Flow Rate. 
 
Study Design 
 
Descriptive study, comparative method. 
 
Setting 
  
→ Diabetic OP of RMMCH 
→ Division of PMR, RMMCH 
 
Participants 
 
50 diabetic females and 50 controls. 
 
Methods 
 
50 Type 2 diabetic and 50 controls were selected. Their fasting blood 
sugar values, PEFR, duration of diabetes, anthropometric details were collected & 
documented. PEFR values between diabetic & controls were compared. 
 
Results 
 
 Peak expiratory flow rate is significantly higher for diabetics compared to 
controls (‘t’ test value 26.810 significant at 0.01 level). There is significant 
association, significant at .01 level) ie PEFR is less as duration of diabetes is 
more. But there is no association between the value of FBS and PEFR (‘r’ value is 
-.176).  
 
Conclusion 
 
 Peak expiratory flow rate is significantly reduced in diabetics compared to 
controls and there is strong association exists between duration of diabetes and 
peak expiratory flow rate, ie. as duration of diabetes is more PEFR is less. 
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INTRODUCTION 
 
Diabetes mellitus is a clinical syndrome characterized by hyperglycemia 
due to absolute or relative deficiency of insulin1. Type 2 diabetes mellitus is a 
serious, progressive condition associated with number of chronic complications 
that are mainly a consequence of macro vascular & micro vascular damage2. 
Cardiovascular disease, nephropathy, diabetic retinopathy, neuropathy and lung 
damage are the important complications of diabetes mellitus3. 
  
Evidence3, 4, 5, 6 supports the involvement of lungs in subjects with diabetes 
mellitus. Thickened alveolar walls, alveolar capillary walls, the pulmonary 
arteriolar walls has been observed in diabetes mellitus3,4. Collagen, elastic 
changes as well as has also identified in diabetes mellitus7. Elastic structure of the 
lung supports the intrathoracic airways & helps to maintain their patency. Hence 
patients with diabetes are at risk for developing chronic airflow obstruction 
(suggested by Michal David Gold man) 7. 
 
Peak Expiratory Flow Rate (PEFR) is the highest flow that can be 
achieved during a forced expiration from maximal inspiration8. It measures the 
ease with which the lungs are resistance in the large airways and expiratory 
muscle strengths effort8. The PEFR can be measured using a wright’s peak flow 
meter. It is one of the simplest way of measuring serial changes in airways 
obstruction over a period of time9. 
 
Contrary report has been obtained in the relationship between pulmonary 
function and diabetes mellitus. While some authors have reported normal 
pulmonary function10 others found abnormalities in lung volumes, pulmonary 
mechanism & diffusing capacity11, 12, 13, 14, 15.  
 
Moreover the relationship like duration of diabetes, age, height, and 
weight with lung function has not explained in many studies. Hence the aim of the 
present study is to compare the peak expiratory flow Rate of Diabetic patients 
with normal populations. 
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REVIEW OF LITERATURE 
 
1. Abdul Majeed AI Dress et al16 in their work on “Lung function in type 2 
Saudi diabetic patients” studied the effects of type 2 diabetes mellitus on lung 
function and to determine its gravity in relation to duration of disease. 32 
healthy type II diabetic patients were randomly selected with age ranging 
from 24-73 years. They were matched with another 40 control healthy male 
subjects in terms of age, height and weight. In conclusion lung function in 
type 2 diabetic patients is impaired by a decrease in FVC, PEF as compared to 
their matched controls. 
 
2. Sanjeev Sinha et al17 evaluated pulmonary functions including respiratory 
muscle strength in patients with type 2 Diabetes mellitus and to determine 
their correlations with anthropometric profile, glycemic control, 
microangiopathic diabetic complications. The result shows that there was no 
difference among the three groups for FVC, FEV & PEFR. The study shows 
that the impairment of pulmonary diffusion capacity for carbon monoxide was 
common in type II diabetes mellitus in Asian Indian Patient having 
microangiopathy.  
 
 
3. Niranjan , et al19, studied cardiopulmonary function during exercise in young 
subjects with long standing insulin-dependent diabetes mellitus who have no 
clinical cardiopulmonary disease to determine the relationships of aerobic 
capacity , gas exchange, ventilatory power requirement and cardiac output to 
chronic glycemic control. The result shows that Maximal work load & oxygen 
uptake were markedly impaired in chronically hyperglycemic diabetic patients 
associated with significant restriction of lung volume, Lung diffusing capacity 
and stroke index during exercise. Membrane diffusing capacity was 
significantly reduced at a given cardiacindex. The normoglycemic patients 
consistently showed less impairment than the hyperglycemic patients. 
 
4. Benbassat CA et al20, did work on “pulmonary function in patients with 
diabetes mellitus” studied the pulmonary function in a group of patients with 
diabetes using a combined cardiopulmonary exercise test. The result shows 
that the spirometric values are preserved in patients with diabetes mellitus and 
there is no defect in diffusing capacity. Cardio vascular factors may account 
for impaired physical performance. 
 
5. Boulbou MS, et al21, did the study to explore the possible relationship between 
lung function and circulating levels of adhesion molecules in diabetes. They 
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concluded that the diabetic subjects showed lower pulmonary volumes and 
variation in DLCO by changing posture from sitting to supine position, and 
they also show increased levels of E-selectin. A possible explanation is 
impaired pulmonary microvasculature, because adhesion molecules seen to be 
sensitive markers of endothelial activation and damage seen in diabetes. 
 
 
6. Boulbou MS, et al22, assessed the nature of pulmonary dysfunction in type 1 
diabetes and the relationship of pulmonary function tests to diabetic factors 
and complications. This study indicates that type 1 diabetic patients have 
reduced TLC & DL (CO) features of pulmonary restrictive dysfunction. There 
was no correlation between abnormal pulmonary function and the presence of 
other diabetic complications. 
 
7.  Makkar.P, et al26, studied the ventilator pulmonary function tests (VPFT) in 
type one diabetes mellitus and to correlate it with duration, meticulous 
metabolic control and various complications of diabetes. The result shows that 
spirometric evaluation in type one diabetes mellitus showed varying 
derangements in the different parameters of PFTS, suggestive of dominantly 
restrictive with some obstructive pattern as indicated by significant decline in 
FVC, PEFR and MEF 15%.  
 
8. Wendy A. Davis27 examined prospectively the relationship between diabetes 
glycemic control and spirometric measures. The result shows there was 
reduced lung volumes and air flow limitation are likely to be chronic 
complications of type 2 diabetes, the seventy of which relates to glycemic 
exposure. Airflow limitation is a predictor of death in type 2 diabetes after 
adjusting for other recognized risk factors. 
 
9. Maurizio Marvisia et al28, assessed the presence of pulmonary function 
abnormalities in patients with NIDDM and to verify the possible associations 
between diabetic renal microangiopathy, retinopathy and diabetes control they 
concluded that pulmonary function  abnormalities in particular a reduction  in 
diffusion capacity are common in patients with NIDDM and signs of diabetes 
microangiopathy. 
 
 
10. .Kemal ozsahina et al29 detected the function and permeability of alveolar 
basement membrane using carbon monoxide diffusion capacity and 
technetium 99m.diethyltriaaminepenta acetic acid (99m Tc-DTPA) aerosol 
scintigraphy methods. Authors aimed to determine the alveolar basement 
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membrane damage using these two methods. Carbone monoxide diffusion 
capacity showed no difference between the two groups. Aerosol scintigraphy 
was significantly decreased in the diabetes group and alveolar capillary 
permeability was significantly decreased than in control group. The 
permeability of alveolar basement membrane can reduce in respect to diabetes 
duration and poor metabolic control. 
 
11. M Sandler, et al5, clarified the issue of pulmonary dysfunction in diabetes 
mellitus; lung mechanics & Co transfer were investigated in 22 young non-
smoking, insulin dependent diabetic patients and an equall number of matched 
healthy subjects. The transfer factor expressed per unit alveolar volume was       
also significantly lower in diabetic than in the control group. There was 
evidence of mild abnormal lung mechanics and or a decreased pulmonary 
capillary blood volume in 16 (73%) of the diabetic group. 
 
 
12. Matsubara T, et al6, examined the pulmonary function and microscopic 
change of the lungs of diabetic patients compared with those of non-diabetic 
patients to assess the diabetic microangiopathy in lungs. The alveolar capillary 
walls, the pulmonary arteriolar walls and the alveolar walls had thickened 
significantly in the diabetic patients.  
 
METHODOLOGY 
 
Aim 
 
To compare the peak expiratory flow rate of diabetic patients with normal 
populations and to study the association of duration of diabetes Fasting blood 
sugar value in relation to Peak Expiratory Flow Rate. 
 
Study Design 
 
Descriptive study, comparative method. 
 
Settings 
 
→ Diabetic OP of RMMCH 
→ Division of PMR, RMMCH 
 
Participants 
 
 50 diabetic females & 50 controls. 
 
Methods 
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Study purpose & procedures were explained to each subject. A prior 
informed written consent was obtained. Diabetic patients were selected randomly 
from the outpatient department of diabetes from RMMCH Annamalai University. 
Controls were chosen from the sample population in & around Chidambaram 
town. 
 
Selection Criteria 
 
 Age Group 40 – 75 years. 
 Only females were selected. 
 Only type 2 diabetes patients were included 
 Subjects with associated Respiratory disorders were not selected 
 Obese  participants and those were involved in regular exercise were 
not chosen 
 
Measurement Tools 
 
 
Peak Expiratory flow rate was measured in liters/second using mini 
wright’s peak flow meter. The subjects were instructed to blow the air as fast as 
possible through the device after taking maximal inspiration. Best of the 3 
readings was recorded. 
 
Fasting blood sugar was noted from the recent readings of the case sheet, 
where as readings for controls were measured using glucometer. 
 
Information regarding the age of the subject and duration of diabetes 
mellitus was recorded in the proforma. The relationship between diabetes mellitus 
and peak expiratory flow rate in association with FBS value and duration of 
diabetes were analyzed with the help of statistical tools.  
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STATISTICAL ANALYSIS 
 
Table 1 
Showing t-test for Diabetic and Control group with PEFR Score 
 
Groups N Mean SD t-value P value 
Diabetic 50 186.80 29.58 
26.810 0.000 (P<0.01)  
Control 50 334.60 24.51 
   SD  –  Standard Deviation                                     P value  –  Probability value  
 
 
The t-value is found to be 26.810 and it is greater than the table value of 
2.57. Hence it is significant at 0.01 level. Therefore the stated alternate hypothesis 
is accepted and null hypothesis is rejected. So it is concluded that there is a 
significant difference between Diabetic and Control group with PEFR scores. 
 
 
Table 2 
Correlation between Durationof diabetes and PEFR  
 PEFR 
Duration -0.602** 
       ** Correlation is significant at the 0.01 level  
The above correlation result shows that there is a negative and significant 
relationship between the Duration and PEFR (-0.602). This indicates that there is 
a relationship among the factors.   
Comparison between Duration  of diabetes and PEFR  
To find out the significance difference between the mean of Duration of 
diabetes and PEFR , ’t’ test was applied and the results are presented in table.  
 
 
8 
 
Showing t-test for Duration of diabetes  and PEFR  
Groups N Mean SD t-value P value 
Duration 50 5.02 2.71 
40.932 0.000 (P<0.01)  
PEFR 50 186.60 29.67 
    SD – Standard Deviation                                  P value – Probability value  
 
The t-value is found to be 40.932 and it is greater than the table value of 
2.57. Hence it is significant at 0.01 levels. Therefore the stated alternate 
hypothesis is accepted and null hypothesis is rejected. So it is concluded that there 
is a significant difference between Duration and PEFR group. 
 
 
 
Table 3 
Correlation between FBS and PEFR Score  
 PEFR 
FBS -0.176 
 
The above correlation result shows that there is a negative and no 
significant relationship between the FBS and PEFR (-0.176). This indicates that 
there is a no relationship among the factors.   
Table 4 
Comparison between Diabetic & Control group with BMI Score 
To find out the significance difference between the mean of Diabetic and 
Control group with BMI score, 't' test was applied and the results are presented in 
table.  
Showing t-test for Diabetic and Control group with BMI Score 
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Groups N Mean SD t-value P value 
Diabetic 50 22.22 2.60 
0.735 
0.466 
(P>0.01) 
NS 
Control 50 22.68 3.56 
SD – Standard Deviation      NS – Not significant     P value – Probability value  
 
The t-value is found to be 0.735 and it is less than the table value of 2.57. 
Hence it is not significant. Therefore the stated alternate hypothesis is rejected 
and null hypothesis is accepted. So it is concluded that there is a no significant 
difference between Diabetic and Control group with BMI scores. 
 
 
DISCUSSION 
 
In the present study, the relationship between type 2 DM & PEFR were 
studied. In addition, whether there is any relationship exists between duration of 
diabetes, level of FBS & PEFR is also analyzed. The current study results 
demonstrated that there is significant relationship between diabetes & PEFR .ie. 
PEFR is significantly lower in diabetic females compared to controls. Moreover 
as duration of diabetes is more the further reduced. But there is no significant 
relationship between level of FBS value and PEFR ie., PEFR is not dependent 
upon the level of FBS value. 
In the present study PEFR is chosen as outcome measure for measuring 
pulmonary function because PEFR is measured with the help of simple Wright’s 
Peak Expiratory Flow meter device & it is cost effective too. The previous 
investigations of lung status in diabetes demonstrated that there is a collagen and 
elastic change observed in the airways which may result increased airway 
resistance &expiratory flow rate of air flow. The above findings support the use of 
PEFR as a tool for the study. 
The current study is correlated with Abdul Majeed Al Dress et al. They all 
demonstrated significant decrease in  PEFR for diabetes .The other common 
parameters of Ventilatory function examined in previous studies are carbon 
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monoxide diffusion capacity,  MEF &thickening of the pulmonary basal lamina. 
But very few studies have examined the relationship between duration of diabetes, 
level of FBS & PEFR. The current study results show that there is strong 
relationship between duration of diabetes & PEFR. When duration of diabetes is 
high, there is significant decrease in PEFR value. No significant difference was 
observed for level of FBS score and PEFR. Hence duration of diabetes has further 
detrimentional effect of diabetic lung. 
In the current study BMI & Age of the diabetics & controls are matched in 
order to prevent extraneous variable influencing study results. It is recommended 
to study the other lung function parameters, most in future to determine the 
impact of diabetes on lung function. It is further suggested to include more study 
sample, both sexes & Type 1 diabetes to better analyze the performance of lung 
function to identify the possible mechanism. 
   
CONCLUSION 
Peak expiratory flow rate is significantly reduced in diabetics compared to 
controls and there is strong association exists between duration of diabetes and 
peak expiratory flow rate, ie. as duration of diabetes is more PEFR is less. 
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INTRODUCTION 
Diabetes mellitus is a clinical syndrome characterized by hyperglycemia due to 
absolute or relative deficiency of insulin1. Type 2 diabetes mellitus is a serious, 
progressive condition associated with number of chronic complications that are mainly 
a consequence of macro vascular & micro vascular damage2. Cardiovascular disease, 
nephropathy, diabetic retinopathy, neuropathy and lung damage are the important 
complications of diabetes mellitus3.  
 
Evidence 3, 4, 5, 6 supports the involvement of lungs in subjects with diabetes 
mellitus. Thickened alveolar walls, alveolar capillary walls, the pulmonary arteriolar 
walls has been observed in diabetes mellitus3,4 .Collagen, elastic changes as well as 
microangiopathy of lungs has also identified in diabetes mellitus7. Elastic structure of 
the lung supports the intrathoracic airways & helps to maintain their patency. Hence 
patients with diabetes are at risk for developing chronic airflow obstruction (suggested 
by Michal David Gold man) 7.  
Peak Expiratory Flow Rate (PEFR) is the highest flow that can be achieved 
during a forced expiration from maximal inspiration8. It measures the ease with which 
the lungs are resistance in the large airways and expiratory muscle strengths effort8. 
The PEFR can be measured using a wright’s peak flow meter. It is one of the simplest 
ways of measuring serial changes in airways obstruction over a period of time9.  
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Contrary report has been obtained in the relationship between pulmonary 
function and diabetes mellitus. While some authors have reported normal pulmonary 
function10 others found abnormalities in lung volumes, pulmonary mechanism & 
diffusing capacity11, 12, 13, 14, 15.  
 
Moreover the relationship like duration of diabetes, age, height, and weight with 
lung function has not explained in many studies. Hence the aim of the present study is 
to compare the peak expiratory flow Rate of Diabetic patients with normal 
populations. 
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STATEMENT OF PROBLEM 
 There is a alarming increase in the incidence and prevalence of diabetes 
mellitus particularly in Asian Indian. Many of the recent studies have shown that 
several pathological changes may affect the lungs in patients with type 2 diabetes 
mellitus. 
 The histo-pathological evidence of the involvement of lung in subjects with DM 
showed thickened alveolar walls, alveolar capillary walls and the pulmonary arteriolar 
walls. 
 Peak expiratory flow rate is significantly reduced in diabetics compared to 
controls and there is strong association exists between duration of diabetes and peak 
expiratory flow rate , i.e duration of diabetics is more peak expiratory flow rate is less. 
There are changes in collagen and elastic component of lungs in diabetes. 
Hence, the correlation between lung function and DM need to be studied. 
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NEED FOR THE STUDY 
 Type 2 Diabetes mellitus is increasing worldwide at an alarming rate and 
associated with number of chronic complications. It is more common in 40-70 years of 
age and approximately 10% to 25% of women’s are afflicted by this type 2 diabetes 
mellitus.  
Though so many approaches are used to analyze the pulmonary function test in 
diabetes mellitus patients. Few studies have done effectiveness of lung function test in 
type 1 diabetes mellitus like eg:     
  Boulbou MS, et al22, assessed the nature of pulmonary dysfunction in type 1 
diabetes and the relationship of pulmonary function tests to diabetic factors and 
complications. This study indicates that type 1 diabetic patients have reduced TLC & 
DL (CO) features of pulmonary restrictive dysfunction.  But there is no 
literature evidence available that has documentation of the effectiveness of peak 
expiratory flow rate in patients with type 2 diabetes mellitus. Hence the study intended 
to find whether the peak expiratory flow rate is higher or lower in patients with type 2 
DM compared with controls. 
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OBJECTIVES  
 
To evaluate the peak expiratory flow rate in patients with type 2 diabetes 
mellitus and to compare the findings with normal populations. 
To evaluate the association of duration of diabetes mellitus and to Compare the 
findings with normal populations. 
To evaluate the association of fasting blood sugar value in relation to Peak 
Expiratory Flow Rate.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6 
 
AIM OF THE STUDY 
 
To compare the peak expiratory flow rate of diabetic patients with normal 
populations and to study the association of duration of diabetes mellitus, fasting blood 
sugar value in relation to Peak Expiratory Flow Rate.  
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HYPOTHESIS 
Null hypothesis 
 There is no significant difference in peak expiratory flow rate were compared 
betweens individuals with diabetes mellitus and normal individuals. (H0) 
 
Experimental hypothesis 
 There is a significant difference in peak expiratory flow rate were compared 
betweens individuals with   diabetes mellitus and normal individuals. (H1) 
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REVIEW OF LITERATURE 
‘A Study on Lung function in type 2 diabetes mellitus patients’ Evaluated the 
effects of type 2 diabetes mellitus on lung function and to determine its gravity in 
relation to duration of disease. 32 healthy type II diabetic patients were randomly 
selected with age ranging from 24-73 years. They were matched with another 40 
control healthy male subjects in terms of age, height and weight. In conclusion lung 
function in type 2 diabetic patients is impaired by a decrease in FVC, PEF as compared 
to their matched controls .Abdul Majeed Dress et al16   
 
      A study evaluated pulmonary functions including respiratory muscle strength 
in patients with type 2 Diabetes mellitus and to determine their correlations with 
anthropometric profile, glycemic control, microangiopathic diabetic complications. 
The result shows that there was no difference among the three groups for FVC, FEV & 
PEFR. The study shows that the impairment of pulmonary diffusion capacity for 
carbon monoxide was common in type II diabetes mellitus in Asian Indian Patient 
having microangiopathy.  Sanjeev Sinha et al17 (2004) 
 
   A study by Ramirez et al ., evaluated the effect of different levels of glycemic 
control on the pulmonary function of subjects with type 1 insulin-dependent diabetes 
mellitus. Eighteen subjects with type 1 insulin-dependent diabetes mellitus with no 
history or physical findings of respiratory disease were chosen for the present study. 
Patients with insulin therapy with a standard twice-daily insulin injection regimen 
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(standard treatment group) and a subcutaneous insulin infusion device using insulin 
pump (intensive treatment group) were studied. Glycosylated hemoglobin (HbA1c) 
levels were determined at quarterly intervals in both groups of patients (standard of 
group, n=10; intensive treatment group, n=8). Pulmonary function and diffusing 
capacity for carbon monoxide (DLCO) were measured after 6 years of continuous 
follow-up. They stated that the diffusing capacity for carbon monoxide (DLCO) was 
significantly diminished in the standard treatment group as compared with that in the 
intensive treatment group. Ramirez, et al 18 (1997) 
 
   A study by Niranjan, et al suggested cardiopulmonary function during exercise 
in young subjects with long standing insulin-dependent diabetes mellitus who have no 
clinical cardiopulmonary disease to determine the relationships of aerobic capacity , 
gas exchange, ventilatory power requirement and cardiac output to chronic glycemic 
control. The result shows that Maximal work load & oxygen uptake were markedly 
impaired in chronically hyperglycemic diabetic patients associated with significant 
restriction of lung volume, Lung diffusing capacity and stroke index during exercise. 
Membrane diffusing capacity was significantly reduced at a given cardiacindex. The 
normoglycemic patients consistently showed less impairment than the hyperglycemic 
patients. Niranjan , et al19 (2001) 
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     A study by Benbassat et al assessed the pulmonary function in a group of 
patients with diabetes using a combined cardiopulmonary exercise test. The result 
shows that the spirometric values are preserved in patients with diabetes mellitus and 
there is no defect in diffusing capacity. Cardio vascular factors may account for 
impaired physical performance. Benbassat et al20 (2003) 
 
    Boulbou et al concluded that the diabetic subjects showed lower pulmonary 
volumes and variation in DLCO by changing posture from sitting to supine position, 
and they also show increased levels of E-selectin. A possible explanation is impaired 
pulmonary microvasculature, because adhesion molecules seen to be sensitive markers 
of endothelial activation and damage seen in diabetes. Boulbou, et al21 (2003) 
 
 A study by Boulbou et al assessed the nature of pulmonary dysfunction in type 
1 diabetes and the relationship of pulmonary function tests to diabetic factors and 
complications. This study indicates that type 1 diabetic patients have reduced TLC & 
DL (CO) features of pulmonary restrictive dysfunction. There was no correlation 
between abnormal pulmonary function and the presence of other diabetic 
complications. Boulbou, et al22 (2001) 
 
    A study by Marvis et al aimed to assess the presence of pulmonary function 
abnormalities in patient with NIDDM & to verify the possible association between 
diabetic renal microangiopathy, retinopathy and diabetes control. They concluded that 
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pulmonary function abnormalities in particular a reduction in diffusion capacity are 
common in patient with NIDDM and signs of diabetic micro angiopathy. A possible 
explanation is related to an impaired pulmonary micro-vasculature and alveolar 
epithelia basal lamina. Marvis, et al 23 (1998) 
 
    A study on Alveolar gas exchange patients with type 2 diabetes mellitus  was 
conducted to quantify and compare the capacity of gas exchange in patients with type 
2 diabetes mellitus and healthy controls and also to investigate the effects of various 
factor on alveolar capillary permeability. This study demonstrated the decreased 
alveolar gas exchange capacity in diabetes patients compared with healthy controls. 
Guvener, et al24 (1999) 
 
  A study was done to examin the relationship between diabetes glycemic control 
and spirometric measures. Devis et al concluded that the reduced lung volumes and 
airflow limitation are likely to be chronic complication of type 2 diabetes, the severity 
of which relates to glycemic exposure. Davis et al25  
 
    The spirometric evaluation in type one diabetes mellitus showed varying 
derangements in the different parameters of PFTS, suggestive of dominantly restrictive 
with some obstructive pattern as indicated by significant decline in FVC, PEFR and 
MEF 15%. Makkar., et al26 (2009) 
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   A study by Wendy A. Davis et al examined prospectively the relationship 
between diabetes glycemic control and spirometric measures. The result shows there 
was reduced lung volumes and air flow limitation are likely to be chronic 
complications of type 2 diabetes, the seventy of which relates to glycemic exposure. 
Airflow limitation is a predictor of death in type 2 diabetes after adjusting for other 
recognized risk factors. Wendy A. Davis27 (2003) 
 
    A study assessed the presence of pulmonary function abnormalities in patients 
with NIDDM and to verify the possible associations between diabetic renal 
microangiopathy, retinopathy and diabetes control and they concluded that pulmonary 
function abnormalities in particular a reduction in diffusion capacity are common in 
patients with NIDDM and signs of diabetes microangiopathy. Maurizio Marvisia et 
al28 (2001) 
 
      In a study on Evaluation of pulmonary alveolar- capillary permeability in type 
2 DM  authors aimed to determine the alveolar basement membrane damage using 
these two methods. Carbone monoxide diffusion capacity showed no difference 
between the two groups. Aerosol scintigraphy was significantly decreased in the 
diabetes group and alveolar capillary permeability was significantly decreased than in 
control group. The permeability of alveolar basement membrane can reduce in respect 
to diabetes duration and poor metabolic control. Kemal ozsahina et al29 (2003) 
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A study on the relationship between pulmonary complications and other chronic 
complications in diabete the finding indicates that both renal and pulmonary 
complications of diabetes share a similar microangiopathic background. Ljubic, et al30 
(2003) 
 
In a study on Diabetes mellitus induce a thickening of the pulmonary basal 
lamina  it was found that all parts of the lung are equally affected by Diabetes Mellitus. 
The thickening of BL is of the same magnitude in lung and kidney. There is no 
relationship between the thickening of the lung BL and know duration and type of 
DM. Weynand, et al31  
 
  The possible associations between diabetes mellitus, plasma glucose, forced 
vital capacity and forced expiratory volume in one second was evaluated in a study by 
Lange et al  all age groups of diabetic subjects there was a slight impairment of lung 
function and there was a significant association between reductions in lung function 
and raised plasma glucose concentration. Lange et al32  
 
A study examined the association between the vascular complications of 
diabetes and changes in pulmonary function. The % Diffusion capacity for carbon 
monoxide decreased significantly as the duration of diabetes increased. The reduction 
in other pulmonary function tests (% VC, FEV1 PaO2 & PaCO2) showed no relationship 
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to the duration of diabetes, the degree of microangiopathy or the type of treatment. 
Hiroshi mori, et al33 (1992) 
 
A study clarified the issue of pulmonary dysfunction in diabetes mellitus; lung 
mechanics & Co transfer were investigated in 22 young non-smoking, insulin 
dependent diabetic patients and an equall number of matched healthy subjects. The 
transfer factor expressed per unit alveolar volume was also significantly lower in 
diabetic than in the control group. There was a evidence of mild abnormal lung 
mechanics and or a decreased pulmonary capillary blood volume in 16 (73%) of the 
diabetic group. Sandler, et al5 (1986) 
 
In a study by Matsubara et al, they  examined the pulmonary function and 
microscopic change of the lungs of diabetic patients compared with those of non-
diabetic patients to assess the diabetic microangiopathy in lungs. The alveolar capillary 
walls, the pulmonary arteriolar walls and the alveolar walls had thickened significantly 
in the diabetic patients. Matsubara, et al6 (1991) 
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METHODOLOGY  
Study Design  
Descriptive study, prospective randomized design.  
 
Settings 
Priya clinic and diabetic center, Coimbatore. 
 
Sampling size 
? 50 diabetic females 
? 50 normal population 
Sampling group 
 ?Group A  ? 50 diabetic females 
 ?Group B  ? 50 normal population  
Method  
Study purpose & procedures were explained to each subject. A prior informed 
written consent was obtained. Diabetic patients were selected randomly from the 
diabetic center in (priya clinic/ diabetic center, coimbatore). Normal populations were 
chosen from the sample population in & around the Coimbatore town.  
  
Materials needed 
? Mini wright’s peak flow meter  
? Disposable mouth pieces 
? Proforma sheet and pen 
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Procedure 
? Attached new disposable mouth piece to the peak flow meter 
? Before each use make sure the sliding pointer on the peak flow meter is reset to 
zero mark. 
? Ask the participant to stand up and hold the peak flow meter in horizontal 
position.  
? Take care not to place the fingers over the scale 
? Ask the participants now to take a deep breath in and make a tight seal with 
their lips around the mouth piece.  
? Now, ask the participants to blow out as hard and as fast as they can. 
? Note the number where the sliding pointer has stopped on the scale 
? Reset the pointer to zero  
? Repeat this procedure in five times  
? Record the best of the three trails  
 
 
Inclusion criteria 
? Age Group 40 – 75 years 
? Only females were selected 
? Only type 2 diabetes patients were included 
? Only AGE matched BMI matched normal subjects were included for control 
population 
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Exclusion criteria 
? Subjects with associated Respiratory disorders were not selected 
? Obese participants and those were involved in regular exercise were not chosen 
? Type 1 diabetic patients were excluded 
? BMI greater than 30 were not chosen 
? Pregnancy women were not chosen 
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MEASUREMENT TOOLS 
 
Peak Expiratory flow rate 
 It was measured in liters/second using mini wright’s peak flow meter. The 
subjects were instructed to blow the air as fast as possible through the device after 
taking maximal inspiration. Best of the 3 readings was recorded.  
 
Fasting blood sugar 
 It was noted from the recent readings of the case sheet; where as readings for 
controls were measured using glucometer.  
 
Anthropometric measurement 
This like height & weight was measured using measuring tape and weighing 
machine respectively. BMI was calculated by the formula  
Weight in kg 
Height in m2 
Information regarding the age of the subject and duration of diabetes mellitus 
was recorded in the proforma. The relationship between diabetes mellitus and peak 
expiratory flow rate in association with FBS value and duration of diabetes were 
analyzed with the help of statistical tools.  
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STATISTICAL TOOLS 
In the study, the two groups were compared for the significant difference to 
infer the effect of peak expiratory flow rate in patients with type II diabetic mellitus. 
The statistical tool used in this analysis was paired‘t’ test and correlation, the 
difference of values between diabetic and normal populations were found the mean 
difference of PEFR of group A were compared with group B and correlation of 
duration and FBS were compared with the PEFR in diabetics patients with the 
acquired‘t’ value and the accurate level of significance was analyzed and interpreted.  
 
ARITHMETIC MEAN 
 
The mean of the values was calculated using the formula given below: 
_ 
X = Σx /N 
 
Where,  
 
       X = Arithmetic Mean, 
       
      Σx = Sum of all variables, 
        
       N = Total number of variables. 
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STANDARD DEVIATION 
 
The standard deviation was calculated using the formula given below  
 
 
PAIRED ‘t’ TEST:  
 
 
_ 
X  =   Mean difference  
S2 = Sample variance  
n = Total numbers   
 
CORRELATION 
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STATISTICAL ANALYSIS 
 
Table 1: Showing t-test for Diabetic and Control group with PEFR Score 
 
 
Groups 
 
 
N 
 
Mean 
 
SD 
 
t- value 
 
P- value
 
Diabetic 
 
 
50 
 
186.80 
 
 
29.58 
 
 
26.810 
 
 
0.000 
 
(P<0.01)
 
control 
 
 
50 
 
334.60 
 
24.51 
 
SD – Standard Deviation     P value – Probability value 
 
 The t- value is found to be 26.810 and it is greater than the table of 2.57.  
Hence it is significant at 0.01 level. Therefore the stated alternate hypothesis is  
Accepted and null hypothesis is rejected. So it is concluded that there is a  
Significant  difference between Diabetic and Control group with PEFR scores. 
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Graph 1: Showing mean for diabetic and control group with PEFR Score 
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Table 2: Correlation between duration of diabetes and PEFR 
 
  
PEFR 
 
Duration 
 
-0.602** 
   ** Correlation is significant at the 0.01 level  
 
Result 
The above correlation result shows that there is a negative and significant 
relationship between the duration and PEFR (-0.602). This indicates that there is a 
relationship among the factors. 
Graph 2: Showing mean for duration of diabetes and PEFR 
 
 
 
 
 
 
 
 
 
 
 
 
PEFR 
(l/sec) 
Duration (years) 
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Table 3 : Correlation between FBS and PEFR score 
 
 
 
 
 
Result 
The above correlation result shows that there is a negative and no significant 
relationship between the FBS and PEFR (-0.176). This indicates that there is a no 
relation among the factors. 
 
Graph 3 : Showing mean for duration of FBS and PEFR 
 
 
  
PEFR 
 
FBS 
 
-0.176 
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Table 4 : Showing t – test for Diabetic and Control group with BMI score 
 
Groups 
 
 
N 
 
Mean 
 
SD 
 
t- value 
 
P- value
 
Diabetic 
 
 
50 
 
22.22 
 
 
2.60 
 
 
0.735 
 
0.466 
 
(P>0.01)
 
NS 
 
control 
 
 
50 
 
22.68 
 
3.56 
 
SD -- Standard Deviation     NS – Not Significant   P Value – Probability value 
Result 
 The t- value is found to be 0.735 and it is less than the table value of 2.57. 
Hence it is not significant. Therefore the stated alternate hypothesis is rejected and null 
hypothesis is accepted. So it is concluded that there is a no significant difference 
between Diabetic and Control group with BMI scores. 
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Graph  4: BMI Score for Diabetics and Control Group Participants 
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Table 5 : Showing t – test for Diabetic and Control group with age score 
 
Groups 
 
 
N 
 
Mean 
 
SD 
 
t- value 
 
P- value
 
Diabetic 
 
 
50 
 
52.60 
 
 
10.01 
 
 
0.855 
 
0.397 
 
(P>0.01)
 
NS 
 
control 
 
 
50 
 
50.82 
 
8.55 
 
SD -- Standard Deviation     NS – Not Significant   P Value – Probability value 
Results 
 The t- value is found to be 0.855 and it is less than the table value of 2.57. 
Hence it is not significant. Therefore the stated alternate hypothesis is rejected and null 
hypothesis is accepted. So it is concluded that there is a no significant difference 
between Diabetic and Control group with Age scores. 
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Graph 5: Age Score for Diabetics and Control Group Participants 
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DISCUSSION 
In the present study, the relationship between type 2 DM & PEFR were studied. 
In addition, whether there is any relationship exists between duration of diabetes, level 
of FBS & PEFR is also analyzed. The current study results demonstrated that there is 
significant relationship between diabetes & PEFR .i.e. PEFR is significantly lower in 
diabetic females compared to controls. Moreover as duration of diabetes is more the 
PEFR is further reduced. But there is no significant relationship between level of FBS 
value and PEFR i.e., PEFR is not dependent upon the level of FBS value. 
In the present study PEFR is chosen as outcome measure for measuring 
pulmonary function because PEFR is measured with the help of simple Wright’s peak 
expiratory flow meter device & it is cost effective too. The previous investigations of 
lung status in diabetes demonstrated that there is a collagen and elastic change 
observed in the airways which may result increased airway resistance & expiratory 
flow rate of air flow. The above findings support the use of PEFR as a tool for the 
study. 
The results of current study is concurrent with a study by sanjeev sinha et al., 17  
Abdul Majeed AL Dress et al.,16 Makkar P et al.,26. They all demonstrated significant 
decrease in PEFR of diabetes. The other common parameters of ventilator function 
examined in previous studies are carbon monoxide diffusion capacity, FEV1, FVC, 
MEF & thickening of the pulmonary basal lamina. But very few studies have 
examined the relationship between duration of diabetes, level of FBS & PEFR. The 
30 
 
current study results show that there is strong relationship between duration of diabetes 
& PEFR. When duration of diabetes is high, there is significant decrease in PEFR 
value. No significant difference was observed for level of FBS score and PEFR. Hence 
duration of diabetes has further detrimentional effect of diabetic lung. 
In the current study BMI & Age of the diabetics & controls are matched in 
order to prevent extraneous variable study results. It is recommended to study the other 
lung function parameters, most importantly FVC, FEV1 in future to determine the 
impact of diabetes on lung function. It is further suggested to include more study 
sample, both sexes & Type 1 diabetes to better analyze the performance of lung 
function to identify the possible mechanism. 
Therefore the Peak expiratory flow rate is significantly higher for diabetics 
compared to controls (‘t’ test value 26.810 significant at 0.01 level). ie PEFR is less as 
duration of diabetes is more. But there is no association between the value of FBS and 
PEFR (‘r’ value is -.176).  
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    CONCLUSION 
Peak expiratory flow rate is significantly reduced in diabetics when compared 
to controls (P<0.01) group participants. There is a significant associated between the 
duration of diabetes and PEFR (P<0.01), An inverse relationship was found between 
the PEFR and the duration of diabetes, PEFR was found to be low in the participants 
with longer duration of diabetes and vice versa. There was no association between the 
fasting blood sugar and PERF in diabetic patients.  
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LIMITATIONS 
? Whether the beneficial effects obtained after training will be sustained or not, is 
not known. 
? The study sample size was small. 
? This study only with age group between 40-70 years. 
? The study was done only on type 2 diabetes mellitus patients. 
? Only peak expiratory floe rate meter was used in this study to find out the 
effects on type 2 DM.   
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RECOMMENDATIONS 
 
 
? The result of this study will serve as evidence the effects of peak expiratory 
flow rate in patients with type 2 DM.  
? This study will serve as a reference to further studies in this topic. 
? Further research is recommended in a larger sample group. 
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   APPENDIX –I 
PROFORMA (Diabetic group) 
DEMOGRAPHIC DATA 
 Name     : 
 Age     : 
 Op no     : 
 Address    : 
ANTHROPOMETRIC MEASUREMENTS 
 Height    : …………..cm 
 Weight    : …………...kg 
 BMI     : …………...kg/m2 
DIABETIC DETAILS 
 BLOOD SUGAR VALUE 
 FBS     : …………..mg/dl DOE…….... 
Duration    : …………..years 
  
PEAK EXPIRATORY FLOW RATE : …………………………. Lt/min 
 
 
      SIGNATURE OF THE PATIENT 
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APPENDIX –II 
 
PROFORMA (Control group) 
DEMOGRAPHIC DATA 
 Name     : 
 Age     : 
 Op no     : 
 Address    : 
ANTHROPOMETRIC MEASUREMENTS 
 Height    : …………..cm 
 Weight    : …………...kg 
 BMI     : …………...kg/m2 
 
  
PEAK EXPIRATORY FLOW RATE : …………………………. Lt/min 
 
 
 
      SIGNATURE OF THE PATIENT 
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APPENDIX --III 
  Diabetics 
 
SL. 
NO 
 
Name 
 
PEFR 
Value 
 
Duration    
of diabetics
 
FBS 
value 
 
BMI 
 
Age 
1 Kannamma 300 1 139 23 43 
2 Baby 200 4 149 23 50 
3 Gangaiammal 180 10 200 18 68 
4 rajalakshmi 200 1 150 25 43 
5 Ethiammal 180 6 200 17 75 
6 Rani 150 4 141 18 38 
7 Jayalashmi 130 8 115 25 40 
8 Pushpa 190 5 117 26 40 
9 Saratha 180 6 137 26 58 
10 Bathmavathy 160 6 267 22 68 
11 Ratha 180 3 126 21 56 
12 Sundharambal 200 4 122 24 65 
13 Rahimunisha 150 10 118 17 60 
14 Gandhimathy 150 5 144 24 48 
15 Sakunthala 200 4 132 22 66 
16 Umarani 160 4 102 21 43 
17 Vijaya 180 8 141 21 49 
18 Rajathi 180 4 167 23 65 
19 Shanthi 210 3 120 25 48 
20 Jaibunisa 190 5 230 21 55 
21 Rajalakshmi 220 3 130 21 48 
22 Meenachi 200 5 110 19 58 
23 Kasthri 220 3 102 20 42 
24 Noornishabee 190 5 160 21 46 
25 Anjammal 210 2 99 23 40 
26 Manju 200 2 126 22 63 
27 Sakunthala 200 5 110 19 40 
28 Samsanth 210 3 100 27.5 40 
29 Sarasvathy 190 5 105 23 60 
30 Lakshmi 200 4 97 25 63 
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31 Senthamarai  150 14 108 25 58 
32 Gnanajothy  140 3 140 24 60 
33 Hathambeevi 180 5 118 21 60 
34 Valarmathy 230 5 119 20 40 
35 Dhavamani 240 2 95 20 40 
36 Jaithunbeevi  160 8 125 23 51 
37 Amala  200 5 120 19 43 
38 Madhuram  200 10 108 24 68 
39 Kanagavali  190 5 110 25 55 
40 Malavathi  180 3 99 26 48 
41 Mariyammal  140 10 140 22 63 
42 Malarkodi  180 3 120 22 54 
43 Rajeshwari  210 2 140 18 40 
44 Kamala  190 5 142 19 58 
45 Sugirtha  150 5 130 23 57 
46 Manimegali  180 3 130 23 55 
47 Thamayanthi  140 10 145 26 63 
48 Sugudeena  190 3 125 22 45 
49 Thilagam  190 5 120 25 53 
50 Mehrjbegam  190 5 111 21 43 
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APPENDIX --IV 
CONTROLS 
SL 
NO 
                 
Name 
PEFR 
Value 
BMI Age 
1 Suseela  310 22.2 62 
2 Kuppammal  300 20 45 
3 Sivasutha  380 21 40 
4 Selvarani  330 25 50 
5 Valli 300 27 48 
6 kanagam 310 26 65 
7 Rajkumari 320 21 45 
8 Vasundara 330 20 62 
9 Ambigai 370 21.4 62 
10 Saraswathi 350 24 45 
11 Sundari 360 26 42 
12 Bavani 380 16 50 
13 Anushiya 300 20 48 
14 Elayarani 280 16 52 
15 Senbagavalli 350 18 60 
16 Amirthavalli  300 28 56 
17 Ganambal  330 24 66 
18 Indirani 290 23 60 
19 Amirthavalli 290 30 62 
20 Suganthy 330 27 50 
21 Ganambal 310 17.3 70 
22 Malarkodi 320 19 50 
23 Malarkodi 310 19 42 
24 Sulochana 340 16 40 
25 Jagadhambal 350 27 70 
26 Kalaivani 360 20 40 
27 Bhavani 350 27.6 42 
28 Rajeswari 320 30 40 
29 Gandhi 330 22.95 47 
30 Lashmi 320 22.32 45 
31 Dhanalashmi 340 28.5 40 
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32 Dhanalasmi 330 25 45 
33 Sarikitnissa 350 27 40 
34 Ananthi 350 23 45 
35 Marakatham 320 25 55 
36 Meenachi  350 21 52 
37 Bharathi 380 21 50 
38 Rajayogam 340 21 46 
39 Rajakumari 350 23 50 
40 Punitha 360 19 45 
41 Jayanthi 330 22 45 
42 Kasapdayi 340 24 54 
43 Vanaja 320 26 49 
44 Viji 350 21 50 
45 Buvana 340 21 40 
46 Thangam 340 23 50 
47 Valarmathi 360 21 50 
48 Jaya 350 23 55 
49 Vasanthi 340 22 58 
50 Preethi  370 20 60 
 
 
 
 
 
 
 
 
 
 
 
44 
 
CONSENT FORM 
 
 
I have been informed about the procedures and the purpose of the study. I have 
understood that I have the right to refuse my consent or withdraw it any time during 
the study without adversely affecting my treatment. I am aware that being subjected to 
this study I will have to give my more time for assessments and treatment and these 
assessments do not interfere with the benefits. 
 
I, __________________________, the under signed, give my consent to be a 
participant of this investigations/study program/clinical trial. 
 
 
Signature of the investigator       Signature of 
subject 
Date:           (Name and address) 
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APPENDIX --V 
